{"gao_id": "GAO-13-190R", "published": "2012-12-07T12:00:00Z", "released": "2012-12-10T07:00:00Z", "summary": "", "title": "End-Stage Renal Disease: Reduction in Drug Utilization Suggests Bundled Payment Is Too High", "topics": ["Drugs", "Medicare beneficiaries", "Dialysis", "Urologic diseases", "Health Care", "Anemia", "End-stage renal disease", "Prescription drugs", "Medicare", "Vitamins"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-13-190r", "versions": [{"title": "Full Report (16 pages)", "url": "https://www.gao.gov/assets/gao-13-190r.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/660/650727.txt"}]}